Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Front Biosci (Schol Ed) ; 5(1): 247-60, 2013 01 01.
Artigo em Inglês | MEDLINE | ID: mdl-23277049

RESUMO

Vitamin D3 is a key regulator of vertebrates homeostasis. It is synthesized from the precursor 7-dehydrocholesterol upon UVB exposure in the skin and then hydrolyzed in the liver in position 25, to be finally converted into its active form, 1,25-dihydroxyvitamin D (1,25(OH)2D or calcitriol), in the kidneys. The biological activity of this molecule depends on its binding to the nuclear receptor VDR, which binds VDRE once complexed with RXR-alpha. Despite being present in different types of food, the best way to assume it at physiological levels remains the exposure to UVB radiation at certain hours of the day and at particular angles of the Earth's crust. There is plenty of evidence that altered levels of vitamin D3 are associated with pathological conditions, such as osteoporosis, cancer, immunological and infectious diseases. In this review, we discuss vitamin D3 metabolism, its role in several diseases and the link between vitamin D3 and immune cells.


Assuntos
Colecalciferol/metabolismo , Animais , Colecalciferol/imunologia , Humanos , Infecções/metabolismo , Neoplasias/metabolismo , Osteoporose/metabolismo , Pele/imunologia , Pele/metabolismo
2.
Ann Saudi Med ; 31(4): 360-4, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21808111

RESUMO

BACKGROUND AND OBJECTIVES: An imbalance in cytokine production may be involved in the pathogenesis of chronic C hepatitis. The aim of the study was to investigate circulating levels of interleukin-10 (IL-10) in a selected cohort of patients affected by chronic C hepatitis. DESIGN AND SETTING: Retrospective study based on consecutive hepatitis C virus patients, affected by chronic active hepatitis, attending the general hospital of hepatology unit from June to September 2009 PATIENTS AND METHODS: A total of 49 patients with chronic C hepatitis and 20 healthy control subjects similar in gender and age were examined. Circulating IL-10 was assessed by ELISA commercial kit (R and D Systems) in all investigated subjects. RESULTS: There was no significant difference in IL-10 values between controls and overall patients (P>.05). Nevertheless, among patients, subjects with more severe necroinflammation had higher values than others (P<.001). Moreover, a close relationship was found between IL-10 values and serum aspartate aminotransferase (r=0.61; P<.001). CONCLUSIONS: These findings suggest that IL-10 may be a useful additional marker to assess necroinflammation and to monitor the evolution of liver damage. They also argue for a potential pathophysiological role for IL-10 in the persistence and progression of hepatitis.


Assuntos
Aspartato Aminotransferases/sangue , Hepatite C Crônica/patologia , Inflamação/patologia , Interleucina-10/sangue , Idoso , Biomarcadores/sangue , Estudos de Casos e Controles , Ensaio de Imunoadsorção Enzimática , Feminino , Hepatite C Crônica/sangue , Hepatite C Crônica/virologia , Humanos , Inflamação/virologia , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Índice de Gravidade de Doença
3.
World J Gastrointest Oncol ; 3(4): 49-59, 2011 Apr 15.
Artigo em Inglês | MEDLINE | ID: mdl-21528090

RESUMO

Biliary tract carcinomas are relatively rare, representing less than 1% of cancers. However, their incidence has increased in Japan and in industrialized countries like the USA. Biliary tract tumors have a poor prognosis and a high mortality rate because they are usually detected late in the course of the disease; therapeutic treatment options are often limited and of minimal utility. Recent studies have shown the importance of serum and molecular markers in the diagnosis and follow up of biliary tract tumors. This review aims to introduce the main features of the most important serum and molecular markers of biliary tree tumors. Some considerable tumor markers are cancer antigen 125, carbohydrate antigen 19-9, carcinoembryonic antigen, chromogranin A, mucin 1, mucin 5, alpha-fetoprotein, claudins and cytokeratins.

4.
Int J Oncol ; 34(4): 897-903, 2009 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-19287946

RESUMO

Epidemiological and experimental studies have provided evidence that human papillomavirus (HPV) infection is a main player in the development of uterine cervical neoplasms. Migration of cancer cells from the origin tissue to surrounding or distant organs is essential for tumor progression. Many studies of tumor invasion and metastases have focused on the degradation of the extracellular matrix where matrix metalloproteinases (MMPs) play a central role. Two of these enzymes, MMP-2 and MMP-9, have been correlated with the processes of tumor cell invasion and metastasis in human cancers, including uterine neoplasms. It has been shown that the up-regulation of MMPs is associated with progression of cervical uterine neoplasms. This review describes the current understanding of MMP-2 and MMP-9 expression and activity in pre-cancer and cancer lesions of cervical uterine, which may open new strategies for diagnostic and therapeutic interventions.


Assuntos
Carcinoma/diagnóstico , Carcinoma/patologia , Colo do Útero/metabolismo , Metaloproteinase 2 da Matriz/metabolismo , Metaloproteinase 9 da Matriz/metabolismo , Neoplasias do Colo do Útero/diagnóstico , Neoplasias do Colo do Útero/patologia , Proliferação de Células , Progressão da Doença , Feminino , Humanos , Inflamação , Modelos Biológicos , Invasividade Neoplásica , Fases de Leitura Aberta , Prognóstico , Regulação para Cima
5.
J Neuroimmunol ; 196(1-2): 107-15, 2008 May 30.
Artigo em Inglês | MEDLINE | ID: mdl-18452999

RESUMO

The immunosuppressive agent cyclophosphamide (CY) was tested in rat experimental allergic neuritis (EAN), a preclinical model of Guillain Barrè syndrome (GBS). CY prophylaxis (day 0 and 14 post-immunization [p.i.]) effectively prevents clinical and histological signs of EAN and also reduces the cytokine and the NF-kappaB p65 expression in the nervous tissue. When administered therapeutically (day 14th p.i.) to rats with established disease CY only affects the clinical symptoms. Both the prophylactic and therapeutic treatment with CY reduced ex vivo antigen-specific T cell proliferative responses. These results warrant studies with CY in those cases of GBS resistant to conventional therapies.


Assuntos
Ciclofosfamida/uso terapêutico , Síndrome de Guillain-Barré/tratamento farmacológico , Síndrome de Guillain-Barré/prevenção & controle , Imunossupressores/uso terapêutico , Animais , Proliferação de Células/efeitos dos fármacos , Citocinas/metabolismo , Modelos Animais de Doenças , Esquema de Medicação , Síndrome de Guillain-Barré/induzido quimicamente , Síndrome de Guillain-Barré/metabolismo , Síndrome de Guillain-Barré/patologia , Masculino , Proteína P0 da Mielina , Ratos , Nervo Isquiático/efeitos dos fármacos , Nervo Isquiático/metabolismo , Estatísticas não Paramétricas , Fatores de Tempo , eIF-2 Quinase/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...